NO | Արտադրանք | CAS ոչ | Հիմնական որակի ցուցիչ | |||
Մաքրություն | Մաքս. կեղտ | Ընդհանուր լուծիչ մնացորդ | Խոնավություն | |||
1 | FMOC-β-Ala-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | FMOC-D-Ala-D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | FMOC-β-Ala-D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | FMOC-ARG (PBF) -ARG (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | FMOC-β-Ala-arg (pbf) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | FMOC-D-Arg (pbf) -D-arg (pbf) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | FMOC-β-Ala-D-arg (pbf) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | FMOC-HOMOARG (PBF) -HOMOARG (PBF) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | FMOC-β-Ala-Homoarg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | FMOC-ASN (TRT) -SN (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | FMOC-β-Ala-ASN (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | FMOC-ASP (OTBU) -Ափ (OTBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | FMOC-β-Ala-ASP (OTBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | FMOC-CYS (TRT) -CYS (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | FMOC-β-Ala-Cys (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | FMOC-CYS (ACM) -YYS (ACM) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | FMOC-β-Ala-Cys (ACM) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | FMOC-GLN (TRT) -Gln (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | FMOC-β-Ala-Gln (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | FMOC-GLU (OTBU) -Glu (OTBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | FMOC--Ala-Glu (OTBU) -OH.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | Fmoc-β-ala-gly-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | FMOC-OR (TRT) -HIS (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | Fmoc-β-ala-her (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | Fmoc-ile-ile-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | Fmoc-β-ala-ile-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | FMOC-Leu-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | FMOC-β-Ala-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | FMOC-D-Leu-D-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | FMOC-β-Ala-D-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | FMOC-LYS (BOC) -lys (Boc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | FMOC-β-Ala-Lys (Boc) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | FMOC-Lys (Alloc) - ԱԼՈՄ (Alloc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | FMOC-β-Ala-Lys (Alloc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | FMOC-MET-MET-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | FMOC-β-Ala-Met-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | FMOC-ORN (BOC) -HORN (BOC) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | FMOC-β-Ala-Orn (Boc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | FMOC-PHE-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | FMOC-β-Ala-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | FMOC-D-PHE-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | FMOC-β-Ala-D-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | FMOC-PRO-PRO-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | FMOC-β-Ala-Pro-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | FMOC-SER (TBU) -SER (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | FMOC--Ala-ser (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | FMOC-SER (TRT) -SER (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | FMOC-β-Ala-ser (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | FMOC-THR (TBU) -երորդ (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | FMOC-β-Ala-THR (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | FMOC-TRP (BOC) -TRP (BOC) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | FMOC-β-Ala-TRP (BOC) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | FMOC-β-Ala-D-TRP (BOC) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | FMOC-TYR (TBU) -Yr (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | FMOC-β-Ala-Tyr (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | FMOC-D-Tyr (et) -d-tyr (et) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | Fmoc-β-ala-d-t-t-t-t-try | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | FMOC-TYR (ME) -tyr (ME) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | FMOC-β-Ala-Tyr (Me) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | FMOC-Val-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | FMOC-β-Ala-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | FMOC-D-CIT-D-CIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | FMOC-β-Ala-D-Cit-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | FMOC-β-Ala-Dab-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | FMOC- (3- (2-naphthyl) -d-ala) 2-Օ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | FMOC-β-Ala-3- (2-Naphthyl) -D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | FMOC- (3- (3-պիրիդինիլ) -D-Ala) 2-Օ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | FMOC-β-Ala-3- (3-Pyridinyl) -D-Ala-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | FMOC- (4-քլոր-D-PHE) 2-Օհ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | FMOC-β-Ala-4-chloro-d-phe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | FMOC- (D-4aph (TBUCBM)) 2-Օհ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | FMOC-β-Ala-D-4aph (TBUCBM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | FMOC-APH (L-Hor) -աֆ (L-Hor) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | FMOC-β-Ala-Aph (L-Hor) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | FMOC-LYS (IPR, BOC) -lys (IPR, Boc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | FMOC-β-Ala-Lys (IPR, Boc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | FMOC-β-Ala-Aeea-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | FMOC-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | Fmoc-β-ala-aib-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | Fmoc-arg-oh | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | H-arg (pbf) -O | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | FMOC-D-arg-Oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-arg (pbf) -O | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | FMOC-HOMOARG-OH.HCL | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | H-Homoarg (PBF) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | FMOC-D-Homoarg-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-Homoarg (pbf) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | FMOC-ASN-OH | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | H-ASN (TRT) -O | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | Fmoc-asp-oh | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | H-ASH (OTBU) -O | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | FMOC-CYS-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-Cys (TRT) -O | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-Cys (ACM) -OH.hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | Fmoc-gln-oh | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | H-Gln (TRT) -O | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | Fmoc-glu-oh | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | H-Glu (OTBU) -OH.H2O | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100-ը | FMOC-OH-OH | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
101 | H- նրա (TRT) -O | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
102 | Boc- իր-օ | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
103 | FMOC-LYS-OH | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
104 | H-Lys (Boc) -O | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 | H-Lys (Alloc) -O | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
106 | FMOC-ORN-OH.HCL | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
107 | H-Orn (Boc) -O | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
108 | FMOC-SER-OH | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
109 | H-ser (TBU) -O | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
110 | H-ser (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
111 | FMOC-THR-OH.H2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
112 | H-THR (TBU) -O | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
113 | FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
114 | H-TRP (BOC) -O | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
115 | FMOC-D-TRP-OH | 86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
116 | HD-TRP (BOC) -OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
117 | FMOC-TYR-OH | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
118 | H-Tyr (tbu) -O | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
119 | FMOC-D-TYR-OH | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | HD-Tyr (et) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | H-Tyr (Me) -OH.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | FMOC-D-4aph (CBM) -OH | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
123 | HD-4APH (TBUCBM) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | FMOC-LYS (IPR) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
125 | H-Lys (IPR, Boc) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Փոխհատուցում
Genleox- ը ապահովում է հիանալի որակի արտադրանք, եթե հաճախորդի կողմից որեւէ արտադրանքի որակը մեծ քանակությամբ ապացույցներ է առաջացնում բավարար ժամանակացույցով, մենք կտրամադրենք անհրաժեշտ վերլուծություններ եւ գնահատականներ `փոխհատուցումների ընթացակարգերը խթանելու համար:
Արտադրություն
Դեղագործական արտադրանքի կարողությունները հասել են տոննա դասի, քիմիական արտադրանքի կարողությունները հասնում են 100tons + դասի, հնարավորությունները լավ հագեցած են աշխարհի հաճախորդներին սպասարկելու համար:
Հետազոտություն եւ զարգացում
Ամեն տարի R & D թիմի կողմից ստեղծված ծրագիր կա տարբեր նոր ապրանքներ զարգացնելու համար, երբ թիրախների հավաքածու, թիմի յուրաքանչյուր անդամ ստիպված կլինի շարունակել KPI պատասխանատվությունը եւ խրախուսական քաղաքականությունը: